4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Benitec Biopharma Inc. (BNTC) operates in the Biotechnology industry and is headquartered in Hayward, United States with about 19 employees. Its market capitalization is roughly $446 million. In the fiscal year ended 2025-06-30, BNTC reported $0M in revenue and ($38M) in net income.
Benitec Biopharma Inc., a clinical-stage biotechnology company, focuses on the development of novel genetic medicines.
Interactive charts & full statements →
| Income statement | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M |
| Gross Profit | — | — | $0M | $0M |
| Operating Income (EBIT) | ($42M) | ($22M) | ($19M) | ($18M) |
| Net Income | ($38M) | ($22M) | ($20M) | ($18M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M | — |
| Gross Profit | — | — | — | — | $0M | — |
| Operating Income (EBIT) | ($14M) | ($13M) | ($10M) | ($17M) | ($15M) | — |
| Net Income | ($12M) | ($12M) | ($9M) | ($16M) | ($14M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
| Total Assets | $100M | $52M | $4M | $6M |
| Total Liabilities | $2M | $5M | $4M | $3M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive BNTC viewer.
About TickerBase · Data methodology & sources